nigericin has been researched along with paclitaxel in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henne, WA; Kularatne, SA; Low, PS; Santhapuram, HK; Vaitilingam, B; Venkatesh, C; Wang, K | 1 |
He, XH; Li, CG; Mai, FY; Ouyang, DY; Xu, LH; Yang, F; Zeng, CY; Zeng, QZ; Zha, QB; Zhang, CC | 1 |
2 other study(ies) available for nigericin and paclitaxel
Article | Year |
---|---|
Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs.
Topics: Antigens, Surface; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Glutamate Carboxypeptidase II; Glutarates; Humans; Ligands; Male; Molecular Targeted Therapy; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship; Urea | 2010 |
Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages.
Topics: Acetylation; Acetyltransferases; Animals; Bacterial Infections; Cell Line; Disease Models, Animal; Epothilones; Gene Knockdown Techniques; Humans; Immunity, Innate; Inflammasomes; Interleukin-1beta; Macrophages; Mice; Microtubule Proteins; Microtubules; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Paclitaxel; Pyroptosis; Signal Transduction; THP-1 Cells; Tubulin | 2019 |